Taro Pharmaceutical Industries Ltd. (TARO)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
64.83-1.13 (-1.71%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 65.96 |
| Open | 65.10 |
| Bid | 65.08 x 800 |
| Ask | 120.00 x 800 |
| Day's Range | 64.82 - 65.52 |
| 52 Week Range | 53.95 - 80.00 |
| Volume | 5,762 |
| Avg. Volume | 18,926 |
| Market Cap | 2.459B |
| Beta (5Y Monthly) | 1.05 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 10, 2018 |
| 1y Target Est | N/A |
- Simply Wall St.
Does The Market Have A Low Tolerance For Taro Pharmaceutical Industries Ltd.'s (NYSE:TARO) Mixed Fundamentals?
It is hard to get excited after looking at Taro Pharmaceutical Industries' (NYSE:TARO) recent performance, when its...
- Zacks
Taro Pharmaceutical (TARO) Q1 Earnings and Revenues Beat Estimates
Taro (TARO) delivered earnings and revenue surprises of 29.76% and 7.23%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Taro Pharma (TARO) Sees Hammer Chart Pattern: Time to Buy?
Taro Pharmaceutical Industries (TARO) has been struggling lately, but the selling pressure may be coming to an end soon.
© 2021 Verizon Media. All rights reserved.
